Bio-Rad Laboratories, Inc. (BIO) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Hercules, CA, アメリカ. 現CEOは Norman D. Schwartz.
BIO を有する IPO日 1980-02-27, 7,700 名の正社員, に上場 NYSE, 時価総額 $7.99B.
Bio-Rad Laboratories, Inc. is a global manufacturer and distributor of life science research and clinical diagnostic products, serving markets across the United States, Europe, Asia, Canada, and Latin America. The company operates through two primary segments: Life Science, which provides reagents, instruments, and apparatus for research in proteomics, genomics, biopharmaceutical production, and food safety; and Clinical Diagnostics, which develops test systems, informatics software, and quality control products for clinical laboratories and in vitro diagnostics. Bio-Rad serves a diverse customer base including universities, pharmaceutical manufacturers, biotechnology firms, hospital laboratories, and food testing facilities through its direct sales force and network of distributors. Founded in 1952 and headquartered in Hercules, California, the company specializes in products and systems for separating, identifying, analyzing, and purifying complex chemical and biological materials.